In one paragraphArticle in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Emma Lauder *Immunology Program, University of Michigan, Ann Arbor, MI, USA.
Mahnoor Gondal *Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Dongchang ZhaoDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Yaping SunDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Marcin CieslikDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
Funding
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9MTUMOR VACCINES AND BONE MARROW TRANSPLANTATIONP01CA039542 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JAMES L. M. FERRARA · 1985 to 2026
$47.9MMetabolomics CoreP01HL149633 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN, TEWARI, MUNEESH · 2020 to 2024
$11.1MIntestinal tissue intrinsic mechanisms in regulation of GI GVHDR01AI165563 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI PAVAN REDDY · 2022 to 2026
$3.2MCOPII dependent regulation of T cell alloimmunityR01HL152605 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2020 to 2023
$2.4MTargeting Novel DAMP mediated signaling pathways to mitigate GVHDR01CA217156 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2017 to 2022
$1.9MCyTOF XT with Hyperion XTi platformS10OD036336 · OD · BAYLOR COLLEGE OF MEDICINE · PI BEETON, CHRISTINE · 2024 to 2024
$829kBD FACSDiscover S8 Spectral and Imaging Cell SorterS10OD038251 · OD · BAYLOR COLLEGE OF MEDICINE · PI BEETON, CHRISTINE · 2025 to 2025
$563kCancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RR220033NCI NIH HHS P01 CA039542NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA217156NHLBI NIH HHS P01 HL149633NHLBI NIH HHS R01 HL152605NIAID NIH HHS R01 AI165563NIH HHS S10 OD036336NIH HHS S10 OD038251U.S. Department of Health & Human Services | National Institutes of Health (NIH) P01CA039542U.S. Department of Health & Human Services | National Institutes of Health (NIH) P01HL149633U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01AI165563U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01CA217156U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01HL152605
6 · The paper itselfAbstract
Major histocompatibility complex (MHC) class I and class II molecules present antigens to CD8
Indexed as
CD4-Positive T-LymphocytesHistocompatibility Antigens Class IImmunity, CellularAnimalsCD8-Positive T-LymphocytesColonic NeoplasmsCytotoxicity, ImmunologicGraft vs Host DiseaseHumansKiller Cells, NaturalMelanomaMiceMice, Inbred C57BLMice, KnockoutHistocompatibility Antigens Class I
Identifiers
PMID41876718
PMCPMC13132726
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390